Major changes at GMDN usher in new era
This article was originally published in RAJ Devices
Steps are being taken to ensure that the Global Medical Device Nomenclature becomes the globally accepted and sustainable single device naming system that both medical device regulators and the industry want, according to a senior US industry official who will be involved in helping shape the strategic direction of the system. Maureen Kenny reports from the 12th Global Harmonization Task Force conference in Canada.
You may also be interested in...
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.